newsfilter
← Latest News
GlobeNewswire·

Cartesian Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Initiated Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Preliminary data from Phase 2 trial of Descartes-08 in systemic lupus erythematosus expected in 2H25 Initiation of Phase 2 pediatric basket trial of